In a statement Japanese drug maker Shionogi & Co Ltd said, their experimental treatment for COVID-19 has shown rapid clearance of the virus that causes the disease. The pill, S-217622, “demonstrated rapid clearance of the infectious SARS-CoV-2 virus”, said Shionogi… Read More ›
Britain has become the first country in the world to approve a potential game-changing COVID-19 antiviral pill, which was jointly developed by US based Merck & Co Inc and Ridgeback Biotherapeutics, in its effort to fight the Wuhan Coronavirus. Britain’s Medicines… Read More ›
manageria.biz 